Brain Cancer Patients That Respond Better To Treatment May Be Identified By Gene Change
6/01/2011
New research proves that a change in a particular gene can identify which patients with a specific kind of brain cancer will respond better to treatment. Testing for the gene can distinguish patients with a more- or less-aggressive form of glioblastoma, the most common and an often-fatal type of primary brain cancer, and help guide therapy, the researchers say...
International Agency For Cancer Research Classification Of Radiofrequency Electromagnetic Fields
6/01/2011
The Health Protection Agency (HPA) notes the recent IARC classification of radio waves in Group 2B "possibly carcinogenic". Radio waves are very common in the environment and are used in radio and television broadcasts, wireless computer networks, pagers, radar, and cordless and mobile phones. This last use leads to a higher exposure than other uses and is the reason for the IARC review...
Cancer Vaccine Holds Promise In Early Stage Prostate Cancer
6/01/2011
New data from ongoing studies with PROSTVAC®, a vaccine in development for the treatment of prostate cancer, will be presented this weekend at the 2011 ASCO Annual Meeting in Chicago, USA. The data suggest that PROSTVAC® may be able to slow disease progression in early stage prostate cancer...
Diabetic Drug Could Help Prevent The Spread Of Cancer
6/01/2011
A protein activated by certain drugs already approved for treating Type II diabetes may slow or stop the spread of breast tumors...
No Evidence XMRV Plays Role In CFS, Contamination More Likely Explanation Say New Reports
6/01/2011
There is no evidence that the XMRV mouse virus plays a role in the development of chronic fatigue syndrome (CFS), as suggested in a study published in 2009, and the more likely explanation is lab contamination, say two new reports in Science this week, one where researchers say they re-tested patient blood samples and the other where researchers show how XMRV prob...
Survey: 9 Out Of 10 Aussie Men Ignore Skin Cancer Risk During Winter, Australia
6/01/2011
A consumer survey released in time for the first day of winter revealed the vast majority of Australian men (89%) and women (82%) surveyed risk skin cancer by ignoring health warnings to wear sunscreen daily during the winter months. "These Canstar Blue survey results are concerning as health experts agree it is important to include sun protection as a daily ritual all year...
The American Society of Clinical Oncology (ASCO) today launched CancerProgress.Net, a dynamic website demonstrating four decades of progress against cancer. The site is intended to provide an easily accessible, visual history of advances against major types of cancer in every area of patient care, from molecularly targeted therapies to quality of life...
Breakthrough In Understanding Blood Clotting
6/01/2011
Blood clotting is a complicated business, particularly for those trying to understand how the body responds to injury. In a new study, researchers report that they are the first to describe in atomic detail a chemical interaction that is vital to blood clotting. This interaction - between a clotting factor and a cell membrane - has baffled scientists for decades...
Hybrigenics (ALHYG), a bio-pharmaceutical group listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new cancer treatments, today announces that the complete positive results of clinical tolerance Phase IIa study of daily oral inecalcitol in castrate-resistant prostate cancer patients, in combination with the standard three-weekly Taxotere(R...
Do Birth Control Pills Containing Drospirenone Raise Blood Clot Risk? FDA Orders Safety Review
6/01/2011
The FDA informs that new data regarding birth control pills containing drospirenone are being evaluated to determine what the risk of blood clots is. Drospirenone is a synthetic progestin - a female sex hormone. Birth control pills usually contain either progestin or estrogen - they prevent ovulation, among other things to avert pregnancy. The molecular formula of drospirenone is C24H30O3...